Mostrando 4 resultados de: 4
Filtros aplicados
Origen
scopus(4)
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 (Nature Structural & Molecular Biology, (2020), 27, 9, (846-854), 10.1038/s41594-020-0469-6)
OtherAbstract: In the version of this article initially published, author Jiandong Huo’s name was spelt incorrectlyPalabras claves:Autores:Bas A.L., Buttigieg K.R., Carrique L., Carroll M.W., Clare D.K., Coombes N., Dumoux M., Duyvesteyn H.M.E., Elmore M.J., Harrison P.J., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Malinauskas T., Mikolajek H., Moynié L., Naismith J.H., Owens R.J., Radecke J., Ren J., Rijal P., Ruza R.R., Shah P.N.M., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Vogirala V.K., Ward P.N., Weckener M., Zhao Y., Zhou D.Fuentes:scopusNeutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
ArticleAbstract: The SARS-CoV-2 virus is more transmissible than previous coronaviruses and causes a more serious illPalabras claves:Autores:Buttigieg K.R., Carrique L., Carroll M.W., Clare D.K., Coombes N., Dumoux M., Duyvesteyn H.M.E., Elmore M.J., Harrison P.J., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Le Bas A., Malinauskas T., Mikolajek H., Moynié L., Naismith J.H., Owens R.J., Radecke J., Ren J., Rijal P., Ruza R.R., Shah P.N.M., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Vogirala V.K., Ward P.N., Weckener M., Zhao Y., Zhou D.Fuentes:scopusStructural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
ArticleAbstract: The COVID-19 pandemic has had an unprecedented health and economic impact and there are currently noPalabras claves:Autores:Buttigieg K.R., Carrique L., Carroll M.W., Chen C.P., Chen T.H., Cheng C.Y., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Godwin K., Huang C.G., Huang K.Y.A., Huang Y.C., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Lin T.Y., Lin Y.C., Ma C., Malinauskas T., Mongkolsapaya J., Naismith J.H., Owens R.J., Paterson N.G., Radecke J., Ren J., Rijal P., Ruza R.R., Screaton G.R., Shah P.N.M., Shih S.R., Stuart D.I., Supasa P., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopusStructures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
ArticleAbstract: Background: Administration of potent anti-receptor-binding domain (RBD) monoclonal antibodies has bePalabras claves:Antibody cocktail, Antibody-antigen complex, Human monoclonal antibody, In vitro and in vivo function, Receptor-binding domain epitope, SARS-COV-2Autores:Buttigieg K.R., Carroll M.W., Charlton S., Chen C., Chen C.P., Chen X., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Ginn H.M., Harding A.C., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Lien C.E., Lin M.Y., Lin T.Y., Ma C., Qin L., Ren J., Rijal P., Schimanski L., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopus